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Abstract 
Objective: Previously we found that certain fetal imprinted genes represented as an allele score are associated with 
maternal pregnancy glucose concentrations. Recently it was reported that fetal polymorphisms with strong associa-
tions with birth weight tend to mediate these independently of increases in maternal pregnancy glucose concentra-
tions. We therefore investigated whether potential associations between the fetal allele score and birth weight were 
related to maternal glucose concentrations in the Cambridge Baby Growth Study.
Results: The fetal imprinted gene allele score was positively associated with birth weight (β = 63 (17–109) g/risk 
allele, β′ = 0.113, p = 7.6 × 10−3, n = 405). This association was partially attenuated by adjusting for maternal glucose 
concentrations (β = 50 (4–95) g/risk allele, β′ = 0.089, p = 0.03, n = 405). The allele score was also positively associated 
with risk of being large for gestational age at birth (odds ratio 1.60 (1.19–2.15) per risk allele, p = 2.1 × 10−3, n = 660) 
and negatively associated with risk of being small for gestational age at birth (odds ratio 0.65 (0.44–0.96) per risk allele, 
p = 0.03, n = 660). The large for gestational age at birth association was also partially attenuated by maternal glucose 
concentrations. These results suggest that associations between the fetal imprinted gene allele score and size at birth 
are mediated through both glucose-dependent and glucose-independent mechanisms.
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Introduction
Fetal exposure to glucose is thought to be one of the prin-
cipal stimulators of growth in utero [1–3]. It is believed 
that glucose-stimulated fetal insulin secretion stimulates 
growth whether or not pregnancies are affected by dia-
betes [4]. Indeed particularly prior to the third trimester 
of pregnancy when its glucoregulatory function develops, 
the principal roles of fetal insulin are both mitogenic and 
anabolic, such as enhancing the growth of white adipo-
cytes and stimulating triglyceride production and deposi-
tion in them [5].
Genetics can have roles in regulating both maternal 
glucose concentrations in pregnancy and fetal growth 
expressed as offspring birth weight. We recently reported 
associations between fetal imprinted genes repre-
sented as an allele score and both gestational diabetes 
and maternal glucose concentrations in late pregnancy 
[6]. In a birth weight-related genome wide association 
study (GWAS) Beaumont et  al. [7] recently reported 
certain maternal polymorphic variants that were associ-
ated with offspring birth weights where the equivalent 
fetal variants were not. In contrast certain other variants 
were associated with offspring birth weight in both the 
maternal and fetal genes. Interestingly all these mater-
nal variants, where the fetal equivalent were not associ-
ated with offspring birth weights, were also associated 
with maternal glucose concentrations in pregnancy [7]. 
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A subsequent study found that a gene score constructed 
using the principal fetal birth weight variants (from [8]) 
was strongly associated with birth weights indepen-
dently of effects of maternal glucose concentrations [9]. 
The authors of this study concluded that for any level of 
maternal glucose concentration fetal genetics has a major 
impact on growth but acts predominantly through mech-
anisms independent of maternal glucose. However none 
of the fetal variants used to construct the gene score in 
this study were independently associated with maternal 
glucose concentrations. In the current study we therefore 
examined relationships between our fetal imprinted gene 
allele score and measures of size at birth, in particular 
investigating whether any allele score associations with 
size at birth appear to be attenuated by maternal glucose 
concentrations in pregnancy.
Main text
Methods
Cambridge baby growth study
The first phase of the prospective, longitudinal Cam-
bridge Baby Growth Study recruited mothers (and their 
partners and offspring) attending early pregnancy ultra-
sound clinics at the Rosie Maternity Hospital, Cam-
bridge, UK between the years 2001–2009 [6, 10]. At 
around 28  weeks of gestation the mothers underwent 
a 75  g oral glucose tolerance test (OGTT) after fasting 
overnight. Plasma glucose concentrations were meas-
ured using a standard glucose oxidase-based procedure 
on samples collected when fasting and 60 min after the 
consumption of the glucose load. Offspring birth weight 
and gestational age at birth data were collected from 
hospital notes. Large for gestational age (LGA) at birth 
was defined as being in the top decile for birth weight 
adjusted for gestational age. Similarly small for gesta-
tional age at birth (SGA) was defined as being in the bot-
tom decile. In this cohort 96.9% of the offspring were 
Caucasian, 0.8% were mixed race, 0.6% were Afro-Carib-
bean, 0.8% were Oriental and 0.9% were Indo-Asian. The 
current analysis was restricted to pregnancies where both 
fasting and 60  min OGTT glucose concentrations were 
available.
Genotyping and fetal allele score formulation
Blood or mouth swab samples for DNA extraction were 
collected from 845 family (mother, father and baby) trios 
of the 1074 families where maternal OGTT data were 
available. Genomic DNA was extracted from these sam-
ples using an Autopure LS Machine (Qiagen Ltd., Craw-
ley, UK). Allelic transmission to the fetus was imputed 
from the DNA family trio genotypes [6, 10], with the 
genotyping performed using Kompetitive Allele Specific 
PCR assays (by LGC Genomics, Hoddesdon, UK). The 
genotypes that were used in this study were all consist-
ent with Hardy–Weinberg equilibrium (p > 0.05 using 
the χ2 test) and had a repeat genotyping discordancy 
rate of < 1.0%. The unweighted fetal allele score was for-
mulated as previously described [6] using the fetal pater-
nally-transmitted INS-IGF2 rs10770125 and rs2585, and 
maternally-transmitted KCNQ1 rs231841 and rs7929804 
alleles.
Statistical analysis
Associations with offspring birth weight were tested 
using linear regression, adjusted for established co-vari-
ates. Associations with LGA and SGA were tested using 
both logistic and linear regression. P < 0.05 was consid-
ered statistically significant throughout. Data are mean 
(95% confidence interval) unless stated otherwise.
Results
Associations with offspring birth weight
The covariates in the regression models (gestational age 
at birth, sex, parity, maternal pre-pregnancy body mass 
index, pregnancy weight gain and maternal smoking 
during pregnancy) explained 31.5% of the variance in 
the offspring birth weights by themselves. OGTT fast-
ing glucose concentrations were significantly associated 
with offspring birth weights when added to the model 
(β = 0.16 (0.09–0.23) g l/mmol, β′ = 0.150, p = 1.5 × 10−5, 
n = 609), as were OGTT 60  min glucose concentrations 
(β = 0.05 (0.03, 0.07) g l/mmol, β′ = 0.161, p = 4.4 × 10−6, 
n = 602). The fetal allele score was also positively asso-
ciated with birth weight (β = 63 (17–109) g/risk allele, 
β′ = 0.113, p = 7.6 × 10−3, n = 405) (Fig.  1). This asso-
ciation was partially attenuated when adjusting for the 
OGTT fasting and 60 min glucose concentrations (β = 50 
(4–95) g/risk allele, β′ = 0.089, p = 0.03, n = 405), shown 
by the flatter slope of the predicted line of best fit of the 
model (Fig. 1).
Associations with being large or small for gestational age 
at birth
The fetal allele score was positively associated with risk 
of being LGA [odds ratio (OR) 1.60 (1.19–2.15) per risk 
allele, p = 2.1 × 10−3] (Fig.  2a). The association was only 
partially attenuated by adjusting for OGTT fasting and 
60 min glucose concentrations [OR 1.47 (1.09–1.98) per 
risk allele, p = 0.01)]. The fetal allele score was also nega-
tively associated with risk of being SGA [OR 0.65 (0.44–
0.96) per risk allele, p = 0.03] (Fig.  2b). The association 
was not attenuated when adjusting for OGTT fasting and 
60 min glucose concentrations [OR 0.67 (0.49–0.99) per 
risk allele, p = 0.04].
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Discussion
In this study the fetal imprinted gene allele score that 
we had previously shown to be associated with both 
maternal glucose concentrations and gestational diabe-
tes risk [6], was additionally associated with offspring 
birth weight and risk of being LGA or SGA. This is per-
haps not surprising given the enrichment of imprinted 
gene regions identified in the largest birth weight-
related GWAS using fetal genotypes [8]. The effect sizes 
were partially attenuated when the associations were 
further adjusted for week 28 OGTT fasting and 60 min 
maternal glucose concentrations, suggesting that the 
link between the fetal allele score and birth weight is 
mediated through both glucose-dependent and glucose 
independent mechanisms. These findings are therefore 
somewhat inconsistent with the associations reported 
by Hughes et  al. [9] where their fetal gene score was 
associated with birth weight completely independently 
of maternal glucose concentrations. The difference in 
the results of the two studies is probably due to the way 
that the two fetal gene scores were formulated: that 
used by Hughes et al. [9] being put together from fetal 
polymorphisms strongly associated with birth weights 
and our allele score being established using fetal alleles 
found to be associated with maternal glucose concen-
trations. Whilst increased maternal glucose concentra-
tions are known to lead to increased birth weights [4], 
glucose-independent pathways upregulated in gesta-
tional diabetes that could potentially affect offspring 
birth weight include increased placental transport of 
both fatty acids and certain amino acids [11, 12].
The main strengths of this study are its prospec-
tive nature and the use of a novel fetal imprinted gene 
allele score that we found to be robustly associated 
with maternal glucose concentrations, even to genome 
wide significance levels by meta-analysis of three dif-
ferent birth cohorts [6]. Its conclusion is that some 
of the principal fetal imprinted gene variants that are 
associated with maternal glucose concentrations in late 
pregnancy in our studies (fetal paternally-transmitted 
INS-IGF2 rs10770125 and rs2585, and maternally-
transmitted KCNQ1 rs231841 and rs7929804 [6, 10]), 
are collectively associated with birth weight through 
both maternal glucose-dependent and glucose-inde-
pendent mechanisms.
Limitations
• The study has a modest (and variable) sample size 
which restricted its statistical power.
• The lack of validation of the associations in additional 
cohorts.
Fig. 1 Linear fit prediction plots showing the relationships 
between the fetal allele score and standardised birth weight 
residuals (after adjustment for gestational age at birth, sex, parity, 
maternal pre-pregnancy body mass index, pregnancy weight gain 
and maternal smoking during pregnancy). The plots are shown 
with and without further adjustment for maternal OGTT glucose 
concentrations, this adjustment flattening the slope
Fig. 2 The fetal allele score in those born (a) LGA or (b) SGA and 
those not born LGA/SGA, with and without adjustment for maternal 
OGTT glucose concentrations. Data are means (95% confidence 
intervals)
Page 4 of 4Petry et al. BMC Res Notes          (2018) 11:821 
• The lack of adjustment of the p-values for multiple 
testing.
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